Literature DB >> 27847330

Altered mitochondrial quality control signaling in muscle of old gastric cancer patients with cachexia.

Emanuele Marzetti1, Maria Lorenzi1, Francesco Landi1, Anna Picca1, Fausto Rosa2, Fabiana Tanganelli1, Marco Galli1, Giovanni Battista Doglietto2, Fabio Pacelli2, Matteo Cesari3, Roberto Bernabei1, Riccardo Calvani4, Maurizio Bossola2.   

Abstract

Mitochondrial dysfunction is involved in the loss of muscle featuring both aging and cancer cachexia (CC). Whether mitochondrial quality control (MQC) is altered in skeletal myocytes of old patients with CC is unclear. The present investigation therefore sought to preliminarily characterize MQC pathways in muscle of old gastric cancer patients with cachexia. The study followed a case-control cross-sectional design. Intraoperative biopsies of the rectus abdominis muscle were obtained from 18 patients with gastric adenocarcinoma (nine with CC and nine non-cachectic) and nine controls, and assayed for the expression of a set of MQC mediators. The mitofusin 2 expression was reduced in cancer patients compared with controls, independent of CC. Fission protein 1 was instead up-regulated in CC patients relative to the other groups. The mitophagy regulators PTEN-induced putative kinase 1 and Parkin were both down-regulated in cancer patients compared with controls. The ratio between the protein content of the lipidated and non-lipidated forms of microtubule-associated protein 1 light chain 3B was lower in CC patients relative to controls and non-cachectic cancer patients. Finally, the expression of autophagy-associated protein 7, lysosome-associated membrane protein 2, peroxisome proliferator-activated receptor-γ coactivator-1α, and mitochondrial transcription factor A was unvarying among groups. Collectively, our findings indicate that, in old patients with gastric cancer, cachexia is associated with derangements of the muscular MQC axis at several checkpoints: mitochondrial dynamics, mitochondrial tagging for disposal, and mitophagy signaling. Further investigations are needed to corroborate these preliminary findings and determine whether MQC pathways may become target for future interventions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetics; Cachexia; Mitochondrial biogenesis; Mitochondrial dynamics; Mitophagy; Muscle wasting

Mesh:

Substances:

Year:  2016        PMID: 27847330     DOI: 10.1016/j.exger.2016.10.003

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  30 in total

1.  The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6.

Authors:  Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

2.  Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.

Authors:  Daria Neyroud; Rachel L Nosacka; Andrew R Judge; Russell T Hepple
Journal:  J Muscle Res Cell Motil       Date:  2019-04-03       Impact factor: 2.698

3.  Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting.

Authors:  Hawley E Kunz; Jessica M Dorschner; Taylor E Berent; Thomas Meyer; Xuewei Wang; Aminah Jatoi; Rajiv Kumar; Ian R Lanza
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

Review 4.  Circulating Mitochondrial DNA at the Crossroads of Mitochondrial Dysfunction and Inflammation During Aging and Muscle Wasting Disorders.

Authors:  Anna Picca; Angela Maria Serena Lezza; Christiaan Leeuwenburgh; Vito Pesce; Riccardo Calvani; Maurizio Bossola; Ester Manes-Gravina; Francesco Landi; Roberto Bernabei; Emanuele Marzetti
Journal:  Rejuvenation Res       Date:  2018-01-02       Impact factor: 4.663

5.  Mitochondrial dynamics and quality control are altered in a hepatic cell culture model of cancer cachexia.

Authors:  Nishant P Visavadiya; Gabriel S Pena; Andy V Khamoui
Journal:  Mol Cell Biochem       Date:  2020-08-14       Impact factor: 3.396

Review 6.  Understanding sex differences in the regulation of cancer-induced muscle wasting.

Authors:  Ryan N Montalvo; Brittany R Counts; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2018-12       Impact factor: 2.302

7.  Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting.

Authors:  Hawley E Kunz; Jessica M Dorschner; Taylor E Berent; Thomas Meyer; Xuewei Wang; Aminah Jatoi; Rajiv Kumar; Ian R Lanza
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

8.  Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss.

Authors:  Hawley E Kunz; John D Port; Kenton R Kaufman; Aminah Jatoi; Corey R Hart; Kevin J Gries; Ian R Lanza; Rajiv Kumar
Journal:  J Appl Physiol (1985)       Date:  2021-12-23

9.  Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.

Authors:  Adeline Dolly; Thierry Lecomte; Nicolas Tabchouri; Morgane Caulet; Nicolas Michot; Benjamin Anon; Romain Chautard; Yoann Desvignes; Mehdi Ouaissi; Gaëlle Fromont-Hankard; Jean-François Dumas; Stéphane Servais
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-22       Impact factor: 12.063

Review 10.  Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.

Authors:  Brandon N VanderVeen; Dennis K Fix; James A Carson
Journal:  Oxid Med Cell Longev       Date:  2017-07-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.